VivaLNK's Wearable ECG Patch Used in Study of Autonomic Function in Predicting Heart Disease

Wednesday, August 28, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Emory University researchers will use VivaLNK's ambulatory ECG patch to study patients undergoing coronary angiography in order to measure autonomic function

CAMPBELL, Calif., Aug. 28, 2019 /PRNewswire/ -- VivaLNK, a leading provider of connected healthcare solutions,

announces an agreement to provide its medical wearable ECG sensors to Emory University for a study to evaluate autonomic function in predicting coronary artery disease (CAD) and its relationship to depression and long-term outcomes. The study builds upon previous work by Emory researchers titled Circadian Autonomic Inflexibility: A Marker of Ischemic Heart Disease, which associates lower heart rate variability (HRV) with subclinical myocardial ischemia.

The VivaLNK medical wearable ECG patch contains an electrocardiography sensor and accelerometer to capture and generate multiple physiological data including ECG trace, heart rate, RR-interval, and 3-axis motion. About the size of a small bandage, the reusable and rechargeable patch weighs a mere 7.5 grams, and can be worn continuously for 72 hours at-a-time to capture and transmit data in real time.

"VivaLNK's ECG patch is very small and comfortable to wear, which are important factors for clinical use and long-term ECG monitoring," said Amit Shah, MD, Assistant Professor of Epidemiology at the Rollins School of Public Health at Emory University. "In addition, the software development kit makes it easy to use the patch for research and product development purposes."

As part of the study, the device will be used to remotely monitor patients who are undergoing coronary angiography, in order to measure autonomic function. Participants will be monitored using the ECG patch for continuous 72-hour periods in a clinical and ambulatory environment, which offers a more complete picture in a natural setting. The research goal is to better understand the role of the autonomic nervous system in depression and coronary artery disease, and to develop better tools for clinical assessment.

For more information on the VivaLNK ECG Patch visit: https://www.vivalnk.com/ecg-monitor.

About VivaLNKVivaLNK is a provider of connected healthcare solutions for wellness, patient care, and telemedicine. The company's portfolio includes wearable medical grade devices and data analytics applications that continuously monitor the health and well-being of individuals. The company's vision is to improve the quality and accessibility of healthcare worldwide by combining technology, data, and analytics into an integrated solution.

Media Contact:pr@VivaLNK.com

 

Cision View original content:http://www.prnewswire.com/news-releases/vivalnks-wearable-ecg-patch-used-in-study-of-autonomic-function-in-predicting-heart-disease-300907984.html

SOURCE VivaLNK



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store